EVALUATING THE SAFETY OF AND IMMUNE RESPONSE TO HIV-MAG DNA VACCINE WITH OR WITHOUT PLASMID IL-12 ADJUVANT DELIVERED INTRAMUSCULARLY VIA ELECTROPORATION FOLLOWED BY VSV-GAG HIV VACCINE BOOST IN HEALTHY, HIV-UNINFECTED ADULTS: